EMC
30
-26
DRI
74
5
AMT
30
2
GM
55
6
GT
43
2
OMC
37
2
CRM
65
6
NWSA
69
4
JNJ
30
4
SLB
41
2
STX
34
2
PDCO
77
3
AFL
34
6
PX
56
3
NDAQ
46
2
BIIB
36
8
HCA
37
7
LB
16
9
DTE
49
16
PHM
44
4
EMC
30
-26
DRI
74
5
AMT
30
2
GM
55
6
GT
43
2
OMC
37
2
CRM
65
6
NWSA
69
4
JNJ
30
4
SLB
41
2
STX
34
2
PDCO
77
3
AFL
34
6
PX
56
3
NDAQ
46
2
BIIB
36
8
HCA
37
7
LB
16
9
DTE
49
16
PHM
44
4
Financhill
Back

Evaxion Biotech AS Vs. Adaptimmune Therapeutics PLC Industry Stock Comparison

Sell
5

EVAX
Evaxion Biotech AS

Last Price:
$0.90
Seasonality Move:
-43.46%
Sell
20

ADAP
Adaptimmune Therapeutics PLC

Last Price:
$0.60
Seasonality Move:
36.97%
Sell
5
Evaxion Biotech AS (EVAX) is a Sell

Is Evaxion Biotech AS a Buy, Sell or Hold?

  • The current Evaxion Biotech AS [EVAX] share price is $0.92. The Score for EVAX is 5, which is 90% below its historic median score of 50, and infers higher risk than normal.
  • EVAX is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
20
Adaptimmune Therapeutics PLC (ADAP) is a Sell

Is Adaptimmune Therapeutics PLC a Buy, Sell or Hold?

  • The current Adaptimmune Therapeutics PLC [ADAP] share price is $0.60. The Score for ADAP is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
  • ADAP is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

EVAX Stock Price Chart

What is Evaxion Biotech AS's stock price today?

  • The Evaxion Biotech AS share price today is $0.92
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EVAX is experiencing slight buying pressure.

ADAP Stock Price Chart

What is Adaptimmune Therapeutics PLC's stock price today?

EVAX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.29 Sell
Relative Strength Index (14 RSI): 22.46 Sell
Chaikin Money Flow: -5392 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.1 - 1.56) Sell
Bollinger Bands (100): (1.75 - 3.19) Sell

ADAP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.04 Sell
Relative Strength Index (14 RSI): 38.3 Sell
Chaikin Money Flow: 3030174 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.6 - 0.7) Sell
Bollinger Bands (100): (0.69 - 1.09) Sell

EVAX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.04 Sell
20-day SMA: 1.3 Sell
50-day SMA: 1.95 Sell
200-day SMA: 2.95 Sell
8-day EMA: 1.03 Sell
20-day EMA: 1.29 Sell
50-day EMA: 1.8 Sell
200-day EMA: 3.44 Sell

ADAP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.61 Sell
20-day SMA: 0.65 Sell
50-day SMA: 0.72 Sell
200-day SMA: 1.04 Sell
8-day EMA: 0.61 Sell
20-day EMA: 0.64 Sell
50-day EMA: 0.73 Sell
200-day EMA: 0.93 Sell

Evaxion Biotech AS Earnings Growth & EVAX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.57 per share, and an increase next year of $0.05 per share.

Adaptimmune Therapeutics PLC Earnings Growth & ADAP Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.37 per share, and a decrease next year of $0.33 per share.

Evaxion Biotech AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Adaptimmune Therapeutics PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):